Stockreport

GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress

GH Research PLC - Ordinary Shares  (GHRS) 
PDF DUBLIN, Oct. 09, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by [Read more]